Genmab — December 2020
-
God morgen.
-
God morgen
-
Genmab Investor Presentation - December 2020 https://ir.genmab.com/download-library#content
-
Watch this quick video from President and Chief Executive Officer Jan G. J. van de Winkel, Ph.D., to learn more about Genmab and why we put a premium on investing in people. - https://www.genmab.com/careers/ - middle of the page
-
Barrons - New Advances in Treating Difficult Blood Cancers From Johnson & Johnson and Others https://www.barrons.com/articles/recovery-still-uncertain-needs-continued-fiscal-support-oecd-51606826322
-
Oncopeptides starts new trial Melflufen in combo with Dara https://clinicaltrials.gov/ct2/show/NCT04649060?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody+OR+hexabody+OR+Teclistamab+OR+Amivantamab+OR+Talquetamab+OR+Epcoritamab+OR+DuoHexabody&lupd_s=12%2F01%2F2020&draw=2&rank=1
-
Der kommer jo den ene ATH efter hinanden og den sidste var i 2528 og kursen holder sig indenfor kanalen https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/88935_Genmab_e.JPG
-
-
Spændende....:-)
-
En investors spændende tanker om $TRIL og konkurrenter i CD47.
https://drive.google.com/file/d/1izk0BFPtslVRCsui3VzElU2lTNqrA16p/view -
God morgen.
-
God morgen
-
-
AbbVie comments, search for Genmab https://seekingalpha.com/article/4392665-abbvie-abbv-management-on-evercore-isi-3rd-annual-healthconx-conference
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind